 |
|
Bioterrorism on the Home Front
A New Challenge for American Medicine
H. Clifford Lane, MD;
Anthony S. Fauci, MD
JAMA. 2001;286:2595-2597.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
On October 4, 2001, it was announced that a 63-year-old man had been hospitalized in Palm Beach County, Florida, with inhalational anthrax.1 This was the first recognized case of inhalational anthrax in the United States since 1976, and the first in US history to result from an intentional human act. As such, it ushered in a new era for the United States, one in which the hypothetical threat of lethal bioterrorism has become a stark reality. Importantly, the juxtaposition of this event with the vicious terrorist attacks on the World Trade Center and the Pentagon, despite no proven connection at this time, has resulted in a heightened state of concern in the United States and in other countries.
Since October 4 and as of November 7, the Centers for Disease Control and Prevention (CDC) has confirmed a total of 10 cases of . . . [Full Text of this Article]
Author Affiliations: National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.
RELATED ARTICLES
Clinical Presentation of Inhalational Anthrax Following Bioterrorism Exposure: Report of 2 Surviving Patients
Thom A. Mayer, Susan Bersoff-Matcha, Cecele Murphy, James Earls, Scott Harper, Denis Pauze, Michael Nguyen, Jonathan Rosenthal, Donald Cerva, Jr, Glenn Druckenbrod, Dan Hanfling, Naaz Fatteh, Ashna Nayyar, and Elise L. Berman
JAMA. 2001;286(20):2549-2553.
ABSTRACT
| FULL TEXT
Death Due to Bioterrorism-Related Inhalational Anthrax: Report of 2 Patients
Luciana Borio, Dennis Frank, Venkat Mani, Carlos Chiriboga, Michael Pollanen, Mary Ripple, Syed Ali, Constance DiAngelo, Jacqueline Lee, Jonathan Arden, Jack Titus, David Fowler, Tara O'Toole, Henry Masur, John Bartlett, and Thomas Inglesby
JAMA. 2001;286(20):2554-2559.
ABSTRACT
| FULL TEXT
HIV Viral Load Response to Antiretroviral Therapy According to the Baseline CD4 Cell Count and Viral Load
Andrew N. Phillips, Schlomo Staszewski, Rainer Weber, Ole Kirk, Patrick Francioli, Veronica Miller, Pietro Vernazza, Jens D. Lundgren, Bruno Ledergerber, and for the Swiss HIV Cohort Study, the Frankfurt HIV Clinic Cohort, and the EuroSIDA Study Group
JAMA. 2001;286(20):2560-2567.
ABSTRACT
| FULL TEXT
Anthrax
JAMA. 2001;286(20):2626.
PDF
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
In Vitro and In Vivo Characterization of Anthrax Anti-Protective Antigen and Anti-Lethal Factor Monoclonal Antibodies after Passive Transfer in a Mouse Lethal Toxin Challenge Model To Define Correlates of Immunity
Staats et al.
Infect. Immun. 2007;75:5443-5452.
ABSTRACT
| FULL TEXT
Emerging Infectious Diseases: A Clear and Present Danger to Humanity
Fauci
JAMA 2004;292:1887-1888.
FULL TEXT
The Critical Role of Pathology in the Investigation of Bioterrorism-Related Cutaneous Anthrax
Shieh et al.
Am. J. Pathol. 2003;163:1901-1910.
ABSTRACT
| FULL TEXT
The Model State Emergency Health Powers Act: Planning for and Response to Bioterrorism and Naturally Occurring Infectious Diseases
Gostin et al.
JAMA 2002;288:622-628.
ABSTRACT
| FULL TEXT
Inhalation Anthrax: Clinical Features of Bioterrorism-Related Cases
JWatch Infect. Diseases 2001;2001:1-1.
FULL TEXT
|
